Ligand profile
2ZI
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3566 — ankyrin repeat family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
2ZI- PDB
4ufu- UniProt (similar protein)
Q9H2K2- Target protein
- VK055_3566
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 45.8
- −1 ≤ LogP ≤ 5 3.92
- MW ≤ 500 Da 304.3
- LogP ≤ 5 3.92
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 45.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1cccc2c1N=C(NC2=O)c3ccc(cc3)C(F)(F)FCc1cccc2c1N=C(NC2=O)c3ccc(cc3)C(F)(F)F
InChI=1S/C16H11F3N2O/c1-9-3-2-4-12-13(9)20-14(21-15(12)22)10-5-7-11(8-6-10)16(17,18)19/h2-8H,1H3,(H,20,21,22)InChI=1S/C16H11F3N2O/c1-9-3-2-4-12-13(9)20-14(21-15(12)22)10-5-7-11(8-6-10)16(17,18)19/h2-8H,1H3,(H,20,21,22)
GDPZGQDEZJRADO-UHFFFAOYSA-NGDPZGQDEZJRADO-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00644
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 2ZI →
- PDB RCSB structure 4ufu →
- UniProt UniProt Q9H2K2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “2ZI”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3566.
PDB 124
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).